Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy

por Samelson-Jones, Benjamin J., Arruda, Valder R.
Publicado 2018

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A

por Samelson-Jones, Benjamin J., Arruda, Valder R.
Publicado 2020

Emerging therapies for hemophilia: controversies and unanswered questions

por Arruda, Valder R., Doshi, Bhavya S., Samelson-Jones, Benjamin J.
Publicado 2018

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia

por Herrmann, Alyssa, Samelson-Jones, Benjamin J., Brake, Sami, Samelson, Renee
Publicado 2017

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates

por Samelson-Jones, Benjamin J., Finn, Jonathan D., Favaro, Patricia, Wright, J. Fraser, Arruda, Valder R.
Publicado 2020

Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19

por Mejia, Erika J., O'Connor, Matthew J., Samelson-Jones, Benjamin J., Mavroudis, Constantine D., Giglia, Therese M., Keashen, Rachel, Rossano, Joseph, Naim, Maryam Y., Maeda, Katsuhide
Publicado 2022

Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX‐Padua

por Robinson, Mary M., George, Lindsey A., Carr, Marcus E., Samelson‐Jones, Benjamin J., Arruda, Valder R., Murphy, John E., Rybin, Denis, Rupon, Jeremy, High, Katherine A., Tiefenbacher, Stefan
Publicado 2021